Abstract
In the past decades a vast number of oximes have been synthesised in order to identify effective compounds for the reactivation of organophosphorus compound (OP)-inhibited acetylcholinesterase (AChE). Up to now, oxime efficacy has been tested primarily in animal experiments. However, the accretive evidence of substantial species differences regarding kinetic properties of human and animal AChE led to an increasing number of in vitro kinetic studies quantifying the reactivating potency of oximes. These data were shown to provide a basis for the selection of effective oximes and for defining adequate oxime doses in human OP poisoning. This review will discuss experimental and theoretical models for the in vitro assessment of oxime efficacy and will give an overview of the present status in the evaluation of oximes as antidotes against OP poisoning.
Keywords: Oxime, organophosphate, acetylcholinesterase, in vitro study
Current Bioactive Compounds
Title: Kinetic Analysis of Oxime Interactions with Acetylcholinesterase as a Basis for the Evaluation of Oxime Efficacy in Organophosphate Poisoning
Volume: 6 Issue: 1
Author(s): F. Worek, P. Eyer, N. Aurbek and H. Thiermann
Affiliation:
Keywords: Oxime, organophosphate, acetylcholinesterase, in vitro study
Abstract: In the past decades a vast number of oximes have been synthesised in order to identify effective compounds for the reactivation of organophosphorus compound (OP)-inhibited acetylcholinesterase (AChE). Up to now, oxime efficacy has been tested primarily in animal experiments. However, the accretive evidence of substantial species differences regarding kinetic properties of human and animal AChE led to an increasing number of in vitro kinetic studies quantifying the reactivating potency of oximes. These data were shown to provide a basis for the selection of effective oximes and for defining adequate oxime doses in human OP poisoning. This review will discuss experimental and theoretical models for the in vitro assessment of oxime efficacy and will give an overview of the present status in the evaluation of oximes as antidotes against OP poisoning.
Export Options
About this article
Cite this article as:
Worek F., Eyer P., Aurbek N. and Thiermann H., Kinetic Analysis of Oxime Interactions with Acetylcholinesterase as a Basis for the Evaluation of Oxime Efficacy in Organophosphate Poisoning, Current Bioactive Compounds 2010; 6 (1) . https://dx.doi.org/10.2174/157340710790711728
DOI https://dx.doi.org/10.2174/157340710790711728 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Von Willebrand Factor: Drug and Drug Target
Cardiovascular & Hematological Disorders-Drug Targets Is there Any Correlation Between Binding and Functional Effects at the Translocator Protein (TSPO) (18 kDa)?
Current Molecular Medicine Hsp70 Molecular Chaperones: Emerging Roles in Human Disease and Identification of Small Molecule Modulators
Current Topics in Medicinal Chemistry Transmembrane Protein 166 and its Significance
Protein & Peptide Letters Perioperative Management of Patients on Adenosine Diphosphate Inhibitors in the Era of Drug-Eluting Stents: Review of the Literature and Clinical Implications
Current Medicinal Chemistry Flavonoids Influence Epigenetic-Modifying Enzyme Activity: Structure-Function Relationships and the Therapeutic Potential for Cancer
Current Medicinal Chemistry Acute Hypersensitivity Reactions to Chemotherapy Agents: An Overview
Inflammation & Allergy - Drug Targets (Discontinued) GRK2 at the Control Shaft of Cellular Metabolism
Current Pharmaceutical Design Respiratory Hypoxia and Oxidative Stress in the Brain. Is the Endogenous Erythropoietin an Antioxidant?
Current Chemical Biology Micronutrient Biofortification in Rice through New Breeding Techniques (NBTs): Bangladesh Perspective
Current Nutraceuticals Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity
Current Drug Targets Glycogen Phosphoprylase (EC 2.4.1.1) Activity During Cardiopulmonary Bypass in Patients Undergoing Cardiac Surgery
Vascular Disease Prevention (Discontinued) Emerging Therapy for Diabetic Neuropathy: Cell Therapy Targeting Vessels and Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Cytotoxic and Radio-sensitizing Effects of Polyphenolic Acetates in a Human Glioma Cell Line (BMG-1)
Current Pharmaceutical Design Prader-Willi Syndrome: Genetics, Phenotype, and Management
Current Psychiatry Reviews The Role of Stress Proteins in Prostate Cancer
Current Genomics MiR-147: Functions and Implications in Inflammation and Diseases
MicroRNA Post-traumatic Stress Disorder in Heart Failure Patients: A Test of the Cardiac Disease-induced PTSD Hypothesis
Current Psychiatry Research and Reviews Adenosine, Ketogenic Diet and Epilepsy: The Emerging Therapeutic Relationship Between Metabolism and Brain Activity
Current Neuropharmacology Potential Benefits and Limits of Psychopharmacological Therapies in Pervasive Developmental Disorders
Current Clinical Pharmacology